EX-10.4
from 10-Q
99 pages
Certain Identified Information Has Been Excluded From the Exhibit by Marking Such Portions With Brackets (“[***]”) Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Collaboration and License Agreement by and Among Spero Therapeutics, Inc., Innovent Biologics (Suzhou) Co., Ltd., and Fortvita Biologics (USA), Inc. Dated as of July 8, 2026
12/34/56
EX-10.1
from 10-Q
15 pages
Spero Therapeutics, Inc. Amended and Restated 2017 Stock Incentive Plan (As Amended on June 12, 2025) 1. Definitions. Unless Otherwise Specified or Unless the Context Otherwise Requires, the Following Terms, as Used in This Spero Therapeutics, Inc. 2017 Stock Incentive Plan, Have the Following Meanings: Administrator Means the Board of Directors, Unless It Has Delegated Power to Act on Its Behalf to the Committee, in Which Case the Term Administrator Means the Committee. Affiliate Means a Corporation or Other Entity Which, for Purposes of Section 424 of the Code, Is a Parent or Subsidiary of the Company, Direct or Indirect. Agreement Means a Written or Electronic Document Setting Forth the Terms of a Stock Right Delivered Pursuant to the Plan, in Such Form as the Administrator Shall Approve. Board of Directors Means the Board of Directors of the Company
12/34/56